Literature DB >> 33980782

Multisystem Inflammatory Syndrome in Children - A New Syndrome Complicated With Acute Heart Failure Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Momoko Uchida1, Yuichiro Kashima1, Katsunori Mochizuki1, Hiroto Sakamoto1, Kotaro Mori1, Soichiro Ebisawa2, Kanako Takeshige1, Kenichi Nitta1, Koichiro Kuwahara2, Hiroshi Imamura1.   

Abstract

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare syndrome temporally related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MIS-C shares similarities with Kawasaki disease, but left ventricular dysfunction is more common in MIS-C.Methods and 
Results: This study reports the case of a 16-year-old Japanese male patient with MIS-C. Although the initial presentation was severe with circulatory and respiratory failure, the patient recovered completely. Endomyocardial biopsy showed active myocarditis with fibrosis. Immunoglobulin treatment was useful for recovery.
CONCLUSIONS: This is the first reported case of MIS-C in Japan. Cardiologists should be aware of MIS-C, a new disease, occurring during the global SARS-CoV-2 pandemic.

Entities:  

Keywords:  Multisystem inflammatory syndrome in children (MIS-C); Myocarditis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Year:  2021        PMID: 33980782     DOI: 10.1253/circj.CJ-21-0243

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.

Authors:  Yohei Yamaguchi; Kei Takasawa; Hitoshi Irabu; Kanako Hiratoko; Yosuke Ichigi; Ko Hirata; Yumie Tamura; Miki Murakoshi; Motoi Yamashita; Hisae Nakatani; Masuhiro Shimoda; Taku Ishii; Tomohiro Udagawa; Masaki Shimizu; Hirokazu Kanegane; Tomohiro Morio
Journal:  J Infect Chemother       Date:  2022-01-24       Impact factor: 2.065

2.  A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy.

Authors:  Yosuke Mohri; Mariko Shimizu; Tadao Fujimoto; Yuki Nishikawa; Akiko Ikeda; Yusuke Matsuda; Taizo Wada; Chiharu Kawaguchi
Journal:  IDCases       Date:  2022-03-31

Review 3.  Updates on Coronavirus Disease 2019 in Children in Japan.

Authors:  Yuta Aizawa; Sayaka Takanashi; Chikara Ogimi
Journal:  Pediatr Infect Dis J       Date:  2022-07-18       Impact factor: 3.806

4.  The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

Authors:  Tomohiro Katsuta; Naoki Shimizu; Kenji Okada; Keiko Tanaka-Taya; Takashi Nakano; Hajime Kamiya; Kiyoko Amo; Naruhiko Ishiwada; Satoshi Iwata; Makoto Oshiro; Nobuhiko Okabe; Ryutaro Kira; Seigo Korematsu; Shigeru Suga; Takeshi Tsugawa; Naoko Nishimura; Haruka Hishiki; Masashi Fujioka; Mitsuaki Hosoya; Yumi Mizuno; Mahito Mine; Isao Miyairi; Chiaki Miyazaki; Ichiro Morioka; Tsuneo Morishima; Tetsushi Yoshikawa; Taizo Wada; Hiroshi Azuma; Koichi Kusuhara; Kazunobu Ouchi; Akihiko Saitoh; Hiroyuki Moriuchi
Journal:  Pediatr Int       Date:  2021-11-10       Impact factor: 1.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.